Giles Richard B 4
4 · Ampio Pharmaceuticals, Inc. · Filed Sep 11, 2019
Insider Transaction Report
Form 4
Giles Richard B
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2014-06-08−70,000→ 0 totalExercise: $6.96Exp: 2024-06-08→ Common Stock (70,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2012-05-07−100,000→ 0 totalExercise: $2.76Exp: 2022-05-07→ Common Stock (100,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2011-03-31−150,000→ 0 totalExercise: $2.50Exp: 2021-03-31→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-12-12−30,000→ 0 totalExercise: $3.33Exp: 2025-12-12→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2013-03-07−80,000→ 0 totalExercise: $3.95Exp: 2023-03-07→ Common Stock (80,000 underlying) - Award
Stock Option (Right to Buy)
2019-09-09+365,500→ 0 totalExercise: $0.75Exp: 2029-09-09→ Common Stock (365,500 underlying)
Footnotes (6)
- [F1]This option was cancelled by mutual agreement between the company and the reporting person.
- [F2]This option was cancelled by mutual agreement between the company and the reporting person.
- [F3]This option was cancelled by mutual agreement between the company and the reporting person.
- [F4]This option was cancelled by mutual agreement between the company and the reporting person.
- [F5]This option was cancelled by mutual agreement between the company and the reporting person.
- [F6]100% of the stock options award vests and becomes exercisable on the date of the grant date.